201 related articles for article (PubMed ID: 23787565)
1. The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costs.
Page RL; Ghushchyan V; Gifford B; Read RA; Raut M; Crivera C; Naim AB; Damaraju CV; Nair KV
J Occup Environ Med; 2013 Jul; 55(7):761-7. PubMed ID: 23787565
[TBL] [Abstract][Full Text] [Related]
2. Hidden costs associated with venous thromboembolism: impact of lost productivity on employers and employees.
Page RL; Ghushchyan V; Gifford B; Read RA; Raut M; Bookhart BK; Naim AB; Damaraju CV; Nair KV
J Occup Environ Med; 2014 Sep; 56(9):979-85. PubMed ID: 25046319
[TBL] [Abstract][Full Text] [Related]
3. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both.
Ghushchyan V; Nair KV; Page RL
Vasc Health Risk Manag; 2015; 11():25-34. PubMed ID: 25565859
[TBL] [Abstract][Full Text] [Related]
4. The association between employee obesity and employer costs: evidence from a panel of U.S. employers.
Van Nuys K; Globe D; Ng-Mak D; Cheung H; Sullivan J; Goldman D
Am J Health Promot; 2014; 28(5):277-85. PubMed ID: 24779722
[TBL] [Abstract][Full Text] [Related]
5. Cost of care for new versus recurrent acute coronary syndrome patients.
Shetty S; Halpern R; McCollam PL
J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112
[TBL] [Abstract][Full Text] [Related]
6. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
7. Cohort analysis assessing medical and nonmedical cost associated with obesity in the workplace.
Kleinman N; Abouzaid S; Andersen L; Wang Z; Powers A
J Occup Environ Med; 2014 Feb; 56(2):161-70. PubMed ID: 24451611
[TBL] [Abstract][Full Text] [Related]
8. The direct and indirect cost burden of acute coronary syndrome.
Johnston SS; Curkendall S; Makenbaeva D; Mozaffari E; Goetzel R; Burton W; Maclean R
J Occup Environ Med; 2011 Jan; 53(1):2-7. PubMed ID: 21187788
[TBL] [Abstract][Full Text] [Related]
9. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis.
Carls G; Li T; Panopalis P; Wang S; Mell AG; Gibson TB; Goetzel RZ
J Occup Environ Med; 2009 Jan; 51(1):66-79. PubMed ID: 19136875
[TBL] [Abstract][Full Text] [Related]
10. Work-related and health care cost burden of community-acquired pneumonia in an employed population.
Kleinman NL; Yu H; Beren IA; Sato R
J Occup Environ Med; 2013 Oct; 55(10):1149-56. PubMed ID: 24064787
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of brain metastasis among lung cancer patients in the United States.
Guérin A; Sasane M; Dea K; Zhang J; Culver K; Nitulescu R; Wu EQ; Macalalad AR
J Med Econ; 2016; 19(5):526-36. PubMed ID: 26735844
[TBL] [Abstract][Full Text] [Related]
12. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Parasuraman S; Thiel E; Park J; Teschemaker A
J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
[TBL] [Abstract][Full Text] [Related]
13. Health and disability costs of depressive illness in a major U.S. corporation.
Druss BG; Rosenheck RA; Sledge WH
Am J Psychiatry; 2000 Aug; 157(8):1274-8. PubMed ID: 10910790
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of illness of acute coronary syndromes: medical and productivity costs.
Zhao Z; Winget M
BMC Health Serv Res; 2011 Feb; 11():35. PubMed ID: 21314995
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
16. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
17. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
18. An employer perspective on annual employee and dependent costs for pediatric asthma.
Kleinman NL; Brook RA; Ramachandran S
Ann Allergy Asthma Immunol; 2009 Aug; 103(2):114-20. PubMed ID: 19739423
[TBL] [Abstract][Full Text] [Related]
19. Direct and indirect costs associated with Dupuytren's contracture.
Macaulay D; Ivanova J; Birnbaum H; Sorg R; Skodny P
J Med Econ; 2012; 15(4):664-71. PubMed ID: 22369346
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
